6969 — Transcene Income Statement
0.000.00%
- TWD1.07bn
- TWD1.60bn
- TWD360.13m
Annual income statement for Transcene, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 190 | 125 | 200 | 360 |
| Cost of Revenue | ||||
| Gross Profit | 70.1 | 22.6 | 20 | 108 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 203 | 218 | 276 | 343 |
| Operating Profit | -12.9 | -93.3 | -75.7 | 17.4 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 8.7 | -95.5 | -88.1 | -3.63 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 6.89 | -87.5 | -78.9 | -3.55 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 6.89 | -87.5 | -78.9 | -3.55 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 6.89 | -87.5 | -78.9 | -3.55 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.191 | -2.4 | -2.13 | -0.092 |
| Dividends per Share |